Evidence map›Paper›PMID 28101605›Full record

GuidelineIntensive care medicine2017

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.

Andrew Rhodes, Laura E Evans, Waleed Alhazzani, Mitchell M Levy, Massimo Antonelli, Ricard Ferrer, Anand Kumar, Jonathan E Sevransky, Charles L Sprung, Mark E Nunnally and 49 more

34 registry-linked trialsAbstract readConsensus StatementPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Intensive care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 34 registered trials, which are not on this map. Cited by 2,781 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2,781citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03406494 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Southern Medical University Clinical Research Project Initiative:Efficacy and Safety of a Multicomponent Physical Therapy Program in Mechanically Ventilated Patient With Sepsis

TypeinterventionalSponsorZhujiang HospitalRan2018 to 2021Enrolled800ConditionsSepsisArmsEarly multicomponent physical therapy program
NCT03422159 phase2completednot on this mapstarted 2018, after this paper: background citation

Outcomes of Metabolic Resuscitation Using Ascorbic Acid, Thiamine, and Glucocorticoids in the Early Treatment of Sepsis.

TypeinterventionalSponsorCommunity Medical Center, Toms River, NJRan2018 to 2019Enrolled140ConditionsSepsis, Severe, Septic ShockArmsAscorbic Acid, Thiamine, Hydrocortisone, Sodium Chloride 0.9%
NCT03461900 nacompletednot on this mapstarted 2019, after this paper: background citation

Guided Fluid-balance Optimization With Mini-fluid chALlenge During Septic Shock: A Multicenter, Stepped Wedge Cluster Randomized Trial

TypeinterventionalSponsorUniversity Hospital, BrestRan2019 to 2024Enrolled535ConditionsSeptic ShockArmsMinifluid challenge, Usual practice
NCT03617965 unknown statusnot on this mapstarted 2018, after this paper: background citation

Mortality Due to Septic Shock Associated With Thrombocytopenia in the Intensive Care Unit

TypeobservationalSponsorUniversidad de GuanajuatoRan2018 to 2019Enrolled350ConditionsThrombocytopenia, Septic Shock, Sepsis BacterialArmsPlatelet count
NCT03683693 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Procalcitonin to Guide Antibiotic Stop in Neurocritical Care Patients. An Interventional Matched-cohort Study.

TypeinterventionalSponsorGeneral Hospital GroeningeRan2018 to 2020Enrolled132ConditionsSepsisArmsProcalcitonin group
NCT03865602 nacompletednot on this mapstarted 2019, after this paper: background citation

Improving Morbidity During Post-Acute Care Transitions for Sepsis (IMPACTS): A Pragmatic Randomized Evaluation of Implementing Best Practice Care for Sepsis Survivors to Reduce Morbidity and Mortality

TypeinterventionalSponsorWake Forest University Health SciencesRan2019 to 2021Enrolled712ConditionsClinical SepsisArmsSepsis Transition And Recovery (STAR), Usual care
NCT03989609 phase2completednot on this mapstarted 2019, after this paper: background citation

ROle of Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock: Randomized Controlled Trial (RODIS Trial)

TypeinterventionalSponsorKasr El Aini HospitalRan2019 to 2021Enrolled24ConditionsSeptic ShockArmsDexmedetomidine Injection [Precedex], Midazolam
NCT04057872 phase1completednot on this mapstarted 2020, after this paper: background citation

PILOT STUDY in the Use of Therapeutic Plasma Exchange in Adult Patients With Severe Sepsis

TypeinterventionalSponsorAlberta Health Services, CalgaryRan2020 to 2024Enrolled17ConditionsSeptic ShockArmsTherapeutic plasma exchange
NCT04103203 nacompletednot on this mapstarted 2019, after this paper: background citation

Fast Assay for Pathogen Identification - Quasi-Experimental Intervention Study

TypeinterventionalSponsorHasselt UniversityRan2019 to 2020Enrolled1,978ConditionsSepsis, Septic Shock, BacteremiaArmsPathoRobot/ Patho-Doc Test result
NCT04143035 unknown statusnot on this mapstarted 2019, after this paper: background citation

Hemodynamic Resuscitation and Monitoring in Early Sepsis

TypeobservationalSponsorTata Memorial CentreRan2019 to 2023Enrolled500ConditionsSeptic ShockArmsNo Intervention
NCT04156451 nacompletednot on this mapstarted 2019, after this paper: background citation

Effectiveness of Fluid Deresuscitation With Central Venous Pressure Target 0-4 mmHg on Capillary Perfusion Density, Acute Kidney Injury Stage, Cardiac Index, and the Intensive Care Unit Length of Stay in Septic Shock Patients After Resuscitation

TypeinterventionalSponsorIndonesia UniversityRan2019 to 2020Enrolled44ConditionsSeptic ShockArmsFluid resuscitation and furosemide administration (bolus and continuous) with central venous pressure target 8 - 10 mmHg, Fluid deresuscitation and furosemide administration (bolus and continuous) with central venous pressure target 0 - 4 mmHg
NCT04280497 narecruitingnot on this mapstarted 2020, after this paper: background citation

A Multicentre Concealed-Allocation Multi-arms Blinded Randomized Controlled Trial to Identify the Best Sepsis Population for Corticotherapy

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2020 to 2025Enrolled1,800ConditionsSepsisArmsAdministration procedures
NCT04339868 phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Terlipressin Versus Placebo for Septic Shock Refractory to High Doses Catecholamine Vasopressors: A Randomized-controlled Trial

TypeinterventionalSponsorMahidol UniversityRan2020 to 2025Enrolled130ConditionsSeptic Shock, Refractory Shock, Norepinephrine Adverse ReactionArmsTerlipressin, Placebo
NCT04388267 unknown statusnot on this mapstarted 2019, after this paper: background citation

Comparative Study on the Relationship Between Fluid REsponsiveness and Arterial ELASTANCE in Patients With Septic Shock or in the Postoperative Course of Aortic Surgery

TypeobservationalSponsorCentral Hospital, Nancy, FranceRan2019 to 2020Enrolled80ConditionsShock, Septic, Hyperlactatemia, Oliguria, Aortic Aneurysm, AbdominalArmsFluid challenge
NCT04457739 completednot on this mapstarted 2019, after this paper: background citation

Evaluation of Tidal Volume Challenge to Detect Preload-responsiveness in Patients With Acute Respiratory Distress Syndrome (ARDS) During Prone Position

TypeobservationalSponsorBicetre HospitalRan2019 to 2021Enrolled58ConditionsAcute Respiratory Distress Syndrome, Septic Shock, Hemodynamic InstabilityArmsTidal volume challenge, End-expiratory occlusion test, Trendelenburg maneuver
NCT04495946 nacompletednot on this mapstarted 2020, after this paper: background citation

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship: A Hybrid Effectiveness-Implementation Randomized Controlled Trial

TypeinterventionalSponsorWake Forest University Health SciencesRan2020 to 2024Enrolled3,894ConditionsSepsisArmsSepsis Transition and Recovery (STAR) program, Usual care
NCT04653831 nacompletednot on this mapstarted 2020, after this paper: background citation

Treatment With Pirfenidone for COVID-19 Related Severe ARDS An Open Label Pilot Trial

TypeinterventionalSponsorSoroka University Medical CenterRan2020 to 2022Enrolled26ConditionsCovid19, ARDSArmsPirfenidone, Standard of care
NCT04693923 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Capillary Refill Time Response to a Rapid Fluid Challenge in Septic Shock Patients: Pathophysiological Determinants, and Relation to Changes in Systemic, Regional and Microcirculatory Blood Flow

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2021 to 2023Enrolled42ConditionsSeptic ShockArmsFluid challenge
NCT04742764 phase3suspendednot on this mapstarted 2024, after this paper: background citation

Dosing of Extracorporeal Cytokine Removal In Septic Shock (DECRISS): a Prospective, Randomized, Multicenter Clinical Trial

TypeinterventionalSponsorUniversity of PecsRan2024 to 2027Enrolled135ConditionsSeptic ShockArmsStandard medical therapy, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 12 hours, Standard medical therapy plus cytokine removal treatment using Cytosorb, with the adsorber changed in every 24 hours
NCT04811755 unknown statusnot on this map

Is TIme From adMission to surgEry an Independent Prognostic Factor for Survival of Patients With Gastro-intestinal Perforation Associated With Septic Shock: (TIME) An Italian Intersocietary Retrospective and Prospective Observational Trial

TypeobservationalSponsorSan Luigi Gonzaga HospitalRan2009 to 2022Enrolled3,276ConditionsEmergency SurgeryArmsSurgical timing from ED admission to surgery
NCT05042622 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Innovative Solutions to Organ-substituting Technologies in the Treatment of Heart and Pulmonary Failure

TypeinterventionalSponsorNational Research Center for Cardiac Surgery, KazakhstanRan2021 to 2023Enrolled90ConditionsAcute Respiratory Distress Syndrome, Septic Shock, SepsisArmsCytokine adsorber filter, Extracorporeal hemoperfusion cartridge
NCT05090930 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Development of Innovative Technologies for the Treatment of Pulmonary and Heart Failure to Prolong Human's Life

TypeinterventionalSponsorNational Research Center for Cardiac Surgery, KazakhstanRan2021 to 2023Enrolled100ConditionsCardiogenic Shock, Ventricular Arrythmia, Cardiac Arrest With Successful Resuscitation, SepsisArmsHA330 - Jafron Biomedical Co., Ltd., China - extracorporeal hemocorrection, CytoSorb (CytoSorbents Corp., USA) - an extracorporeal cytokine adsorber
NCT05094154 phase4completednot on this mapstarted 2021, after this paper: background citation

Effect of Antibiotic Choice On ReNal Outcomes (ACORN)

TypeinterventionalSponsorVanderbilt University Medical CenterRan2021 to 2022Enrolled2,634ConditionsSepsis, AKI, NeurotoxicityArmsanti-pseudomonal cephalosporin, anti-pseudomonal penicillin
NCT05136183 naunknown statusnot on this mapstarted 2021, after this paper: background citation

CLinical Efficacy of Hemoperfusion With a Cytokine Adsorber in Norepinephrine-Resistant SEptic Shock

TypeinterventionalSponsorMahidol UniversityRan2021 to 2023Enrolled200ConditionsSeptic Shock, Cytokine StormArmsHA-330 Disposable Hemoperfusion Cartridge (Jafron, China)
NCT05211765 unknown statusnot on this mapstarted 2021, after this paper: background citation

Association of Respiratory Variation of Superior Vena Cava in Transthoracic View and Fluid Responsiveness in Critically Ill Patients

TypeobservationalSponsorUniversity of ChileRan2021 to 2024Enrolled100ConditionsShockArmsSuperior vena cava transthoracic evaluation
NCT05264454 nawithdrawnnot on this mapstarted 2022, after this paper: background citation

Effect of High-Flow Nasal Cannula on IVC Measurements Using Point of Care Ultrasound

TypeinterventionalSponsorNova Scotia Health AuthorityRan2022 to 2023Enrolled0ConditionsFluid OverloadArmshigh flow nasal cannulae
NCT05367986 nacompletednot on this mapstarted 2019, after this paper: background citation

Lectro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis

TypeinterventionalSponsorGuangdong Provincial Hospital of Traditional Chinese MedicineRan2019 to 2022Enrolled78ConditionsSepsis, Immune DysfunctionArmselectro-acupuncture
NCT05918705 completednot on this mapstarted 2023, after this paper: background citation

Is the Ratio of Optic Nerve Sheath Diameter to Eyeball Transverse Diameter Correlated with the Prognosis of Sepsis Associated Encephalopathy in Critically Ill Patients

TypeobservationalSponsorZagazig UniversityRan2023 to 2024Enrolled89ConditionsSepsis-associated EncephalopathyArmsUltrasound optic nerve sheath diameter / eyeball transverse diameter ratio
NCT06050759 completednot on this mapstarted 2023, after this paper: background citation

C-Reactive Protein / Albumin Ratio as a Predictive Inflammatory Marker for Postoperative Systemic Inflammatory Response Syndrome and/or Sepsis in Polytraumatized Patients in ICU

TypeobservationalSponsorAin Shams UniversityRan2023 to 2024Enrolled100ConditionsCrpArmsCRP and Albumin level in blood sample
NCT06069206 nacompletednot on this mapstarted 2023, after this paper: background citation

Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes: A Learning Healthcare Pragmatic Randomized Trial

TypeinterventionalSponsorVanderbilt University Medical CenterRan2023 to 2025Enrolled500ConditionsBloodstream Infection, Sepsis Bacterial, MRSA Bacteremia, VancomycinArmsT2Bacteria® Panel (direct-from-blood testing), Usual Care
NCT06125184 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Effect of Vasopressin on Kidney and Cardiac Function in Previously Hypertensive Patients With Septic Shock: A Randomized Clinical Trial

TypeinterventionalSponsorPontificia Universidad Catolica de ChileRan2022 to 2025Enrolled50ConditionsKidney Injury, Acute, Cardiac Function FailedArmsVasopressor test
NCT06954129 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Markers of Nephrotoxicity During Treatment With Antibiotic Combinations: A Pragmatic Clinical Trial

TypeinterventionalSponsorUniversity of PennsylvaniaRan2026 to 2029Enrolled750ConditionsAcute Kidney InjuryArmsVancomycin, Piperacillin-tazobactam, Cefepime
NCT07172451 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy and Safety of Balanced Gelatin Solution for Fluid Infusion in Sepsis Patients Undergoing Emergency Abdominal Surgery: A Multicenter, Adaptive Designed, Randomized Controlled Trial

TypeinterventionalSponsorShanghai Zhongshan HospitalRan2026 to 2028Enrolled318ConditionsSepsis, Intra-Abdominal InfectionsArmsBalanced Gelatin Solution, Acetate Ringer's Solution
NCT07179276 narecruitingnot on this mapstarted 2026, after this paper: background citation

Veno-arterial Carbon Dioxide Partial Pressure Difference (CO2gap) for Early Resuscitation of Septic Shock: A Multicenter Prospective Randomized Trial (CARBON)

TypeinterventionalSponsorUniversity Hospital, Clermont-FerrandRan2026 to 2027Enrolled750ConditionsSepsis - to Reduce Mortality in the Intensive Care Unit, Septic ShockArmsCO2gap-guided resuscitation strategy
3 · Its place in the literature

Who cites it

2,781 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Efficacy and Safety of Procalcitonin-Guided Antibiotic Therapy versus Standard of Care for Sepsis: A Systematic Review and Meta-Analysis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Pooled it
  3. Pooled it
  4. Continuous versus Intermittent Hydrocortisone for the Treatment of Septic Shock: A Systematic Review and Meta-Analysis.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Study on the Role of Galectin-3 in Sepsis.Biochemical genetics · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Beyond the gut microbe: Rethinking infection, microbiome harmony, and the one-health continuum.World journal of gastrointestinal pharmacology and therapeutics · 2026
    Review

2,721 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

59 authors.

Andrew RhodesSt. George's Hospital, London, England, UK. andrewrhodes@nhs.net.
Laura E EvansNew York University School of Medicine, New York, NY, USA.
Waleed AlhazzaniMcMaster University, Hamilton, ON, Canada.
Mitchell M LevyBrown University School of Medicine, Providence, RI, USA.
Massimo AntonelliInstituto di Anestesiologia e Rianimazione, Università Cattolica del Sacro Cuore, Rome, Italy.
Ricard FerrerVall d'Hebron University Hospital, Barcelona, Spain.
Anand KumarUniversity of Manitoba, Winnipeg, MB, Canada.
Jonathan E SevranskyEmory University Hospital, Atlanta, GA, USA.
Charles L SprungHadassah Hebrew University Medical Center, Jerusalem, Israel.
Mark E NunnallyNew York University School of Medicine, New York, NY, USA.
Bram RochwergMcMaster University, Hamilton, ON, Canada.
Gordon D RubenfeldSunnybrook Health Sciences Centre, Toronto, ON, Canada.
Derek C AngusUniversity of Pittsburgh Critical Care Medicine CRISMA Laboratory, Pittsburgh, PA, USA.
Djillali AnnaneHospital Raymond Poincare, Garches, France.
Richard J BealeSaint Thomas Hospital, London, England, UK.
Geoffrey J BellinghanUniversity College London Hospitals, London, England, UK.
Gordon R BernardVanderbilt University Medical Center, Nashville, TN, USA.
Jean-Daniel ChicheService de Reanimation Medicale, Paris, France.
Craig CoopersmithEmory University Hospital, Atlanta, GA, USA.
Daniel P De BackerCHIREC Hospitals, Braine L'Alleud, Belgium.
Craig J FrenchWestern Hospital, Victoria, Australia.
Seitaro FujishimaKeio University School of Medicine, Tokyo, Japan.
Herwig GerlachVivantes-Klinikum Neukölln, Berlin, Germany.
Jorge Luis HidalgoKarl Heusner Memorial Hospital, Belize Healthcare Partners, Belize City, Belize.
Steven M HollenbergCooper Health System, Camden, NJ, USA.
Alan E JonesUniversity of Mississippi Medical Center, Jackson, MS, USA.
Dilip R KarnadJupiter Hospital, Thane, India.
Ruth M KleinpellRush University Medical Center, Chicago, IL, USA.
Younsuk KohASAN Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Thiago Costa LisboaHospital de Clinicas de Porto Alegre, Porto Alegre, Brazil.
Flavia R MachadoFederal University of Sao Paulo, Sao Paulo, Brazil.
John J MariniRegions Hospital, St. Paul, MN, USA.
John C MarshallSaint Michael's Hospital, Toronto, ON, Canada.
John E MazuskiWashington University School of Medicine, St. Louis, MO, USA.
Lauralyn A McIntyreOttawa Hospital, Ottawa, ON, Canada.
Anthony S McLeanNepean Hospital, University of Sydney, Penrith, NSW, Australia.
Sangeeta MehtaMount Sinai Hospital, Toronto, ON, Canada.
Rui P MorenoUCINC, Centro Hospitalar de Lisboa Central, Lisbon, Portugal.
John MyburghUniversity of New South Wales, Sydney, NSW, Australia.
Paolo NavalesiUniversità dellla Magna Graecia, Catanzaro, Italy.
Osamu NishidaFujita Health University School of Medicine, Toyoake, Aich, Japan.
Tiffany M OsbornWashington University School of Medicine, St. Louis, MO, USA.
Anders PernerRigshospitalet, Copenhagen, Denmark.
Colleen M PlunkettRush University Medical Center, Chicago, IL, USA.
Marco RanieriUniversità Sapienza, Rome, Italy.
Christa A SchorrCooper Health System, Camden, NJ, USA.
Maureen A SeckelChristiana Care Health Services, Newark, DE, USA.
Christopher W SeymourUniversity of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Lisa ShiehStanford University School of Medicine, Stanford, CA, USA.
Khalid A ShukriKaust Medical Services, Thuwal, Saudi Arabia.
Steven Q SimpsonUniversity of Kansas Medical Center, Kansas City, KS, USA.
Mervyn SingerWolfson Institute of Biomedical Research, London, England, UK.
B Taylor ThompsonMassachusetts General Hospital, Boston, MA, USA.
Sean R TownsendCalifornia Pacific Medical Center, San Francisco, CA, USA.
Thomas Van der PollUniversity of Amsterdam, Amsterdam, Netherlands.
Jean-Louis VincentErasmé University Hospital, Brussels, Belgium.
W Joost WiersingaUniversity of Amsterdam, Amsterdam, Netherlands.
Janice L ZimmermanHouston Methodist Hospital, Houston, TX, USA.
R Phillip DellingerCooper Health System, Camden, NJ, USA.

Funding

Sepsis subtypes: biology, treatment, and bedside applicationR35GM119519 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Christopher W. Seymour · 2016 to 2026
$4.9M
NIGMS NIH HHS R35 GM119519
6 · The paper itself

Abstract

objectiveTo provide an update to "Surviving Sepsis Campaign Guidelines for Management of Sepsis and Septic Shock: 2012".

designA consensus committee of 55 international experts representing 25 international organizations was convened. Nominal groups were assembled at key international meetings (for those committee members attending the conference). A formal conflict-of-interest (COI) policy was developed at the onset of the process and enforced throughout. A stand-alone meeting was held for all panel members in December 2015. Teleconferences and electronic-based discussion among subgroups and among the entire committee served as an integral part of the development.

methodsThe panel consisted of five sections: hemodynamics, infection, adjunctive therapies, metabolic, and ventilation. Population, intervention, comparison, and outcomes (PICO) questions were reviewed and updated as needed, and evidence profiles were generated. Each subgroup generated a list of questions, searched for best available evidence, and then followed the principles of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system to assess the quality of evidence from high to very low, and to formulate recommendations as strong or weak, or best practice statement when applicable.

resultsThe Surviving Sepsis Guideline panel provided 93 statements on early management and resuscitation of patients with sepsis or septic shock. Overall, 32 were strong recommendations, 39 were weak recommendations, and 18 were best-practice statements. No recommendation was provided for four questions.

conclusionsSubstantial agreement exists among a large cohort of international experts regarding many strong recommendations for the best care of patients with sepsis. Although a significant number of aspects of care have relatively weak support, evidence-based recommendations regarding the acute management of sepsis and septic shock are the foundation of improved outcomes for these critically ill patients with high mortality.

Indexed as

Anti-Bacterial AgentsBlood GlucoseCalcitoninCritical IllnessErythrocyte TransfusionFluid TherapyHumansNutrition AssessmentPatient Care PlanningRenal Replacement TherapyRespiration, ArtificialSepsisShock, SepticVasoconstrictor AgentsAnti-Bacterial AgentsBlood GlucoseCalcitoninVasoconstrictor AgentsEvidence-based medicineGrading of Recommendations Assessment, Development, and Evaluation criteriaGuidelinesInfectionSepsisSepsis bundlesSepsis syndromeSeptic shockSurviving Sepsis Campaign

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

and 28 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.